U.S.is expected to fuel the growth of North America dermatology devices market in the future years 2016 to 2022” – A new report by Data Bridge Market Research

North America Dermatology Devices Market, By Product Type (Dermatology Treatment Devices and Dermatology Diagnostic Devices), By End-User (Hospitals and Clinics) By Country (U.S., Canada, Mexico) – Trends and Forecast to 2022

The increasing incidences of skin disorders, such as melanoma & non-melanoma skin cancer, vascular & pigmented lesions, varicose veins, psoriasis, and acne, coupled with increasing awareness amongst the population has triggered the market for both diagnostic and treatment devices. In the U.S., melanoma accounted for about 3.0% of the skin cancer cases found, with 70,000-80,000 new cases being diagnosed, annually. Superficial spreading melanoma was found to be one of the most common forms of melanoma, encompassing 65.0% of the total melanomas cases registered. This type of melanoma arises in a pre-existing mole, growing horizontally before invading vertically. According to the latest statistics made available by National Cancer Institute, about 2.5 to 3.0 million skin lesions were biopsied in the U.S., of which melanoma represents less than 5% of skin cancer. In 2012, 44,250 men and 32,000 women were diagnosed with melanoma of the skin, and 8700 of these total cases resulted in death.

Heine Optotechnik, OptomedOy, FotoFinder Systems, Michelson diagnostics, Genesis Biosystems, Ellipse A/S, Alma Lasers, Palomar Technologies, GE Healthcare, Philips Healthcare, Verisante Technology, Inc., MELA Sciences, Inc., Verisante Technology, Inc., Welch Allyn, Carl Zeiss Meditec, Inc., Hitachi, Leica Microsystems, Olympus, GE Healthcare, Phillips Healthcare, Toshiba Medical Systemsand Siemens Medical Systems, are some of the key players engaged in this market.

Mail sales@databridgemarketresearch.com

Or visit